Key market opportunities include advancements in research, medicine, diagnostics, and biotechnology through CRISPR. There is potential for innovative solutions and ethical exploration in gene editing, ...
Market Realist on MSN
How Colossal Biosciences uses CRISPR and the safeguards behind the science
Colossal Biosciences is establishing standards for how biotechnology can responsibly support biodiversity conservation in an ...
Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based ...
The rapid evolution of CRISPR/Cas genome editing has redefined the possibilities of cellular and gene therapy, enabling ...
Researchers at Gladstone Institutes (CA, USA) have mapped the human immune response using next-generation CRISPR technology known as base editing. Using this tool, the team was able to identify ...
The type I CRISPR protein Cas3 works like Pac-Man, chomping away at a continuous stream of nucleotides with intrinsic activity for introducing targeted large deletions from a few hundred base pairs to ...
24/7 Wall St. on MSN
Colossal’s Ben Lamm says invasive species is a $5.4 trillion problem. Here’s his solution
Quick Read Ben Lamm, CEO of Colossal Biosciences, argues that gene drive technology is the only scalable solution to invasive ...
In the first of a new series of GEN Keynote Webinars, Professor Rodolphe Barrangou, PhD (North Carolina State; EIC, The CRISPR Journal) offers a front-row perspective of the CRISPR revolution, the ...
CRISPR promises revolutionary cures, but its edits aren’t always perfect. To tackle hidden risks, UC San Diego researchers developed the ICP system, which fingerprints genetic edits and shows how they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results